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ApoptosisNeurovascular dysfunction arising from endothelial cell damage is an early pathogenic event that contributes to
the neurodegenerative process occurring in Alzheimer's disease (AD). Since the mechanisms underlying endo-
thelial dysfunction are not fully elucidated, this studywas aimed to explore the hypothesis that brain endothelial
cell death is induced upon the sustained activation of the endoplasmic reticulum (ER) stress response by
amyloid-beta (Aβ) peptide, which deposits in the cerebral vessels in many AD patients and transgenic mice.
Incubation of rat brain endothelial cells (RBE4 cell line) with Aβ1–40 increased the levels of several markers of
ER stress-induced unfolded protein response (UPR), in a time-dependentmanner, and affected the Ca2+ homeo-
stasis due to the release of Ca2+ from this intracellular store. Finally, Aβ1–40 was shown to activate both
mitochondria-dependent and -independent apoptotic cell death pathways. Enhanced release of cytochrome c
frommitochondria and activation of the downstream caspase-9 were observed in cells treated with Aβ1–40 con-
comitantlywith caspase-12 activation. Furthermore, Aβ1–40 activated the apoptosis effectors' caspase-3 and pro-
moted the translocation of apoptosis-inducing factor (AIF) to the nucleus demonstrating the involvement of
caspase-dependent and -independent mechanisms during Aβ-induced endothelial cell death. In conclusion,
our data demonstrate that ER stress plays a signiﬁcant role in Aβ1–40-induced apoptotic cell death in brain endo-
thelial cells suggesting that ER stress-targeted therapeutic strategiesmight be useful in AD to counteract vascular
defects and ultimately neurodegeneration.
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ights reserved.1. Introduction
According to the ‘Amyloid Cascade Hypothesis’, the accumulation of
amyloid-beta (Aβ) in brain parenchyma is responsible for the neurode-
generative process in Alzheimer's disease (AD) [1]. Furthermore, nu-
merous studies support that neurovascular dysfunction contributes to
neurodegeneration and cognitive decline and thus have a major role
in AD pathogenesis (reviewed in [2]). First, vascular risk factors such
as diabetes, obesity, hypercholesterolemia, hypertension, atherosclero-
sis, and stroke signiﬁcantly increase the risk to develop AD [3,4]. Second,
combined evidences from neuroimaging and neuropathological studies
show that signs of vascular pathology develop early in AD and occur be-
fore the disease becomes symptomatic [5,6]. Third, deﬁcient clearance
of Aβ across the blood–brain barrier (BBB) has been described in the
brain of AD patients [2]. Finally, Aβ depositionwas found in the cerebral
microvasculature of AD transgenic mice and in cerebrovessels in many
AD patients and contributes to the age-dependent degeneration of cere-
bral vasculature and development of cerebral amyloid angiopathy, char-
acterized by dysfunction of brain capillary endothelium [7,8]. This
dysfunction correlates with the toxic effects of Aβ on endothelial cells
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vessels as well as in whole animals [9–12]. Aβ induces irreversible mor-
phological and functional changes of ECs resulting in suppression of
their proliferative activity and reduced survival [13,14]. In addition,
Aβ-induced apoptosis was demonstrated in cultured cerebral ECs [9],
but the underlying mechanisms have not been fully elucidated. It was
reported that endoplasmic reticulum (ER) stress is a stimulus that initi-
ates apoptotic cell death pathways in vascular ECs [15,16], but its role in
Aβ-induced endothelial dysfunction has not been addressed yet.
The ER is the principal organelle responsible for proper folding/
processing of nascent proteins and Ca2+ homeostasis. Perturbed ER
function leads to a state known as ER stress. To ameliorate this stress,
mammalian cells possess a homeostatic set of protein signaling path-
ways and transcription factors termed the unfolded protein response
(UPR). The UPR utilizes three types of ER-resident sensor proteins,
inositol-requiring protein-1 (IRE1), protein kinase RNA-like ER kinase
(PERK), and activating transcription factor 6 (ATF6), that are activated
after the ER-resident chaperone glucose-regulated protein of 78 kDa
(GRP78, also known by immunoglobulin binding protein, BiP) dissoci-
ates from their ER luminal domains and initiates ER-to-nucleus signal-
ing cascades to maintain the homeostasis [17,18]. However, persistent
and severe ER stress triggers apoptotic cascades resulting in cell death
[19]. Upon dimerization and autophosphorylation, PERK inactivates
the α subunit of eukaryotic translation initiation factor 2 (eIF2α) by
phosphorylation at Ser51, required for 80S ribosome assembly, thus
inhibiting general protein translation through a decrease in the GTP-
bound form of eIF2α, but increasing the translation of the transcription
factor ATF4. In the nucleus, ATF4 induces the transcription of several
genes involved in controlling the UPR and growth arrest and DNA
damage-inducible protein-34 (GADD34). GADD34 induces a negative
feedback and dephosphorylates eIF2α [20,21]. IRE1α removes a
26-base intron of mRNA of X-box binding protein-1 (XBP-1) inducing
a more efﬁcient translation and a more stable protein. The resulting
XBP-1 protein with 54 kDa instead of 33 kDa comprises the original
N-terminal DNA binding domain and a transactivation domain in the
C-terminal and is a transcription factor that regulates genes involved
in the ER-associated degradation pathway and increases the expression
of several ER resident chaperones, such as GRP78 [22]. Upon dissocia-
tion from GRP78, ATF6 migrates to the Golgi apparatus where it is
cleaved to release a transcription factor that upregulates genes involved
in ampliﬁcation of folding capacity such as chaperones including
GRP78 and also genes for protein disulﬁde isomerases, CAAT/enhancer
binding protein homologous protein (CHOP, also termed GADD153),
XBP-1 [21,23], and genes involved in angiogenesis and autophagy
[20]. During prolonged ER stress, apoptotic cell death is induced by
the c-jun N-terminal kinase (JNK) pathway, by caspases, including the
ER membrane-associated caspase-12 (in murine or the homologue
caspase-4 in humans) or upregulation of the transcription of CHOP
[19,24]. CHOP functions to block cells transition fromG1 to S phase dur-
ing cell cycle progression and can directly activate GADD34 increasing
oxidation reactions at the ER [25]. Furthermore, CHOP down-regulates
Bcl-2 and induces the translocation of Bax to mitochondria and subse-
quent cytochrome c release and activation of the apoptosis-effector
caspase-3 [26]. Besides, ER and mitochondria are physically close and
in contact and communicate through Ca2+ signals [27]. In normal con-
ditions, Ca2+ released from ER is taken up by mitochondria and in-
creases ATP production. Nevertheless, an overload in Ca2+ uptake by
mitochondria upon ER Ca2+ release promoted by apoptotic stimuli or
ER stress could induce the release of cytochrome c and other caspase
cofactors leading to apoptotic cell death [27]. In neurons, themitochon-
drial uptake of Ca2+ released form ER is essential to activate the mito-
chondrial apoptotic cell death pathway under Aβ1–40-induced ER
stress conditions [28].
Reports are available describing the engagement of ER stress in AD.
In brain post-mortem samples from early AD patients, but not in
non-demented subjects, ER stress markers have been detected in thetemporal cortex and hippocampus [29]. Moreover, in transgenic mice
modeling AD, increased brain levels of several ER stress markers
have been described [30,31]. The presenilins (PSs, components of the
γ-secretase complex present in the ER membrane) function as low-
conductance, passive ER Ca2+ leak channels and, consequently, familial
AD-linked PS mutations disturb ER Ca2+ homeostasis leading to in-
creased susceptibility to activation of UPR and caspase-4-induced apo-
ptosis [19,32,33]. Nonetheless, mutant PS1 reduces global ER function
since it suppresses the activation of IRE1α, ATF6, and PERK and, as a
result, GRP78/BiP is downregulated in PS1 mutant AD patients [19].
GRP78/BiP is able to bind the amyloid precursor protein (APP)
inhibiting Aβ generation [34,35]. Therefore, mutant PS1 may increase
the generation of Aβ by reducing the levels of GRP78/BiP available to
bind APP. Moreover, aberrant splicing of PS2, almost exclusively ob-
served in the brains of sporadic AD patients, increases the production
of Aβ and the vulnerability to ER stress [36] and, may thus be implicated
in the pathogenesis of this form of the disease.
Our previous in vitro results highlighted the role of ER stress in neu-
ronal dysfunction triggered by Aβ [37,38] but the impact of ER stress in
Aβ-induced endothelial dysfunction has not been investigated yet.
Therefore, the aim of this workwas to analyze themolecular basis of ce-
rebrovascular alterations in AD exploring the hypothesis that Aβ1–40,
which preferentially accumulates in brain vasculature [8,39], damages




Indo-1 acetoxymethyl ester (Indo-1/AM), Alexa Fluor 488 goat
anti-rabbit IgG conjugate, Fura-2 acetoxymethyl ester (Fura-2/AM),
Tetramethylrhodamine methyl ester (TMRM), and Hoechst 33342
were obtained from Molecular Probes (Leiden, The Netherlands). The
synthetic Aβ1–40 peptide was from Bachem (Bubendorf, Switzerland).
Ionomycin, ProteoExtract® Subcellular Proteome Extraction Kit, and col-
orimetric substrates for caspase-3, -9 and -12 (Ac-DEVD-pNA, Ac-LEHD-
pNA, and Ac-LEVD-pNA, respectively) were purchased from Calbiochem
(Darmstadt, Germany). Polyvinylidene diﬂuoride (PVDF) membrane,
goat alkaline phosphatase-linked anti-rabbit and anti-mouse secondary
antibodies, and the enhanced chemiﬂuorescence (ECF) reagent were ac-
quired from Amersham Pharmacia Biotech (Buckinghamshire, UK).
Mousemonoclonal antibody against glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was from Chemicon International Inc. (Temecula,
CA, USA). The Glycergel Mounting Medium was purchased from
DakoCytomation Inc. (Carpinteria, CA, USA). Bio-Rad protein dye assay
reagent, acrylamide, and the prestained Precision Plus Protein All Blue
Standard were purchased from Bio-Rad (Hercules, CA, USA). The In Situ
Cell Death Detection Kit, Fluorescein (with terminal deoxynucleotidyl
transferase dUTP nick-end labeling, TUNEL), and collagenwere obtained
from Roche Applied Science (Mannheim, Germany). Trypsin EDTA solu-
tion, thioﬂavin S (ThS), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide (MTT), anti-α-tubulin mouse monoclonal antibody,
protease inhibitors (leupeptin, pepstatin A, chymostatin, and aprotinin),
thapsigargin, recombinant human basic ﬁbroblast growth factor (bFGF),
oligomycin, carbonyl cyanide 4-(triﬂuoromethoxy)phenylhydrazone
(FCCP), dantrolene sodium, and mouse monoclonal antibody reactive
against ATF4 were obtained from Sigma Chemical Co. (St. Louis, MO,
USA). Rabbit polyclonal antibodies reactive against XBP1 and mouse
monoclonal antibody reactive against TATA-binding protein (TBP)
were acquired from Abcam plc (Cambridge, UK). Mouse monoclonal
antibodies reactive against GRP78 and cytochrome c, and rabbit
polyclonal antibody reactive against caspase-12 were from BD Biosci-
ences (Heidelberg, Germany). Mouse monoclonal antibodies reactive
against CHOP/GADD153 or apoptosis-inducing factor (AIF), and rabbit
polyclonal antibodies reactive against ATF6α or Tom20 were obtained
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clonal antibodies reactive against Bax or cleaved poly(ADP-ribose) poly-
merase 1 (PARP1) (Asp214), and rabbit monoclonal antibody against
Bcl-2 were acquired from Cell Signaling Technology, Inc. (Danvers,
MA, USA). Mem-Alpha medium with Glutamax-1, Nut Mix F-10
W/GLUTAMAX-1, fetal bovine serum (FBS), and geneticinwere acquired
from Invitrogen Life Science (Paisley, UK).
2.2. Culture of rat brain endothelial cell line RBE4 and treatments
The rat brain endothelial cell line RBE4 was provided by Dr. Jon Holy
(University of Minnesota, Duluth, USA). RBE4 is a continuous, immortal-
ized cell line that retains a stable phenotype reminiscent of BBB endothe-
lium in vitro [40]. Cells at passages 10–35 were grown on 75 cm2 tissue
culture ﬂasks coated with 4.15 μg/cm2 collagen in MEM-Alpha medium
with Glutamax-1 and Nut Mix F-10 W/GLUTAMAX-1 (1:1 vol/vol),
supplemented with 10% heat inactivated FBS, 1 ng/ml bFGF and
0.3 mg/ml geneticin. Cells were maintained at 37 °C in a humidiﬁed
atmosphere of 5% CO2/95% air.
RBE4 cells were plated on collagen-coated (4.15 μg/cm2) multiwell
plates at a density of approximately 22,000 cells/cm2 and were then
treatedwith 0.1 or 2.5 μMAβ1–40 during 3–24 h. Thereafter, cell viability,
protein levels of ER stress markers as well as of apoptosis, levels of cyto-
solic Ca2+, mitochondrial membrane potential (Δψmit), and also
caspases-3, -9 and -12-like activities were measured. Alternatively,
RBE4 cells plated in coverslips coated with poly-L-lysine (0.1 mg/ml)
and then collagen (4.15 μg/cm2) were treated with 2.5 μM Aβ1–40 for 3,
6, 12 or 24 h and after thatﬁbrillar content, ATF6 nuclear localization, ne-
crotic/apoptotic cell deathmarkers, and ER Ca2+ content were analyzed.
Synthetic Aβ1–40-HCl was dissolved in sterile water at a concentra-
tion of 6 mg/ml and then diluted to 1 mg/ml (231 μM) in PBS and
stored at−20 °C until use.
2.3. Detection of Aβ ﬁbrils in cell culture
The presence of β-sheet ﬁbrils has been assessed by ThS staining in
RBE4 cells treated with 2.5 μM “fresh” Aβ1–40 during 3 h. In brief, con-
trol and treated cells were washed with PBS buffer (pH 7.4) and were
ﬁxedwith 4%paraformaldehyde for 15 min at RT. The cellswere perme-
abilized with 0.2% Triton X-100 in PBS buffer (pH 7.4), for 2 min, at RT
and were then incubated with a 1% ThS solution for 20 min in the
dark. Cells were subsequently washed with PBS buffer (pH 7.4), with
a 70% ethanol solution (quick wash) and ﬁnally with PBS. Then, cover-
slips mounted in DakoCytomation Fluorescent mounting solution on a
microscope slide for the visualization in a ﬂuorescence microscope
(Zeiss axioskop2, Zeiss, Jena, Germany).
2.4. Analysis of cell viability by the MTT assay
Cell viabilitywas evaluated using theMTT assay, whichmeasures the
ability ofmetabolic active cells to form formazan through cleavage of the
tetrazolium ring of MTT [41]. Brieﬂy, cells were washed in normal sodi-
ummedium (inmM: 132 NaCl, 4 KCl, 1.2 Na2HPO4, 1.4 MgCl2, 6 glucose,
10 HEPES, and 1 CaCl2, pH 7.4) and incubated with 0.5 mg/ml MTT for
2 h at 37 °C. The blue formazan crystals formed were dissolved in an
equal volumeof 0.04 MHCl in isopropanol and quantiﬁed spectrophoto-
metrically by measuring the absorbance at 570 nm using a microplater
reader (SpectraMax Plus 384, Molecular Devices, California, USA). Re-
sults were expressed as the percentage of the absorbance determined
in control cells.
2.5. Analysis of plasma membrane integrity by the lactate dehydrogenase
(LDH) assay
The integrity of the plasmamembranewas evaluated by determining
the release of the cytoplasmic enzyme LDH as previously described [42].The activity of intracellular and released LDH was determined spec-
trophotometrically (Pharma Spec, UV-1700, UV–Visible spectrophotom-
eter, Shimadzu), by following the rate of conversion of reduced
nicotinamide adenine dinucleotide (NADH) to oxidized nicotinamide
adenine dinucleotide (NAD+) at 340 nm. After cell treatment, themedi-
umwas collected (extracellular LDH) and the cells were lysed in 10 mM
HEPES (pH 7.4) plus 0.01% (v/v) TritonX-100 (intracellular LDH) follow-
ed by 3 cycles of freezing (−80 °C) and thawing. In both intra and extra-
cellular aliquots, cell debris were removed by centrifugation at 20,800 g
for 10 min. LDH release into the extracellular mediumwas calculated as
the percentage of total LDH activity (extracellular + intracellular LDH),
and then expressed relatively to the control.
2.6. Quantiﬁcation of apoptotic and necrotic cells by the TUNEL assay and
using Hoechst 33342/propidium iodide staining
Apoptotic cell death was analyzed by the TUNEL assay [28],
performed using an In Situ Cell Death Detection Kit, according to the
manufacturer's directions. ECs cultured on glass coverslipswerewashed
in PBS buffer (pH 7.4) and ﬁxed with 4% (w/v) paraformaldehyde for
30 min at room temperature (RT). Then, slides were rinsed twice in
PBS buffer and immersed in 0.1% (v/v) Triton X-100 supplemented
with 0.1% (w/v) sodium citrate in iced PBS, for 2 min, to permeabilize
the cells. Coverslips were rinsed again 3 times with PBS and incubated
with TUNEL mixture for 1 h at 37 °C, in the dark. Finally, coverslips
were rinsed 3 times with PBS and mounted with Glycergel Mounting
Medium onto a microscope slide for visualization in a ﬂuorescence mi-
croscope (Zeiss axioskop2, Zeiss, Jena, Germany) with a 40× objective.
DNAse-treated cells were used as a positive control.
The number of apoptotic and necrotic cells was analyzed by nuclear
morphology criteria using Hoechst 33342 (which is able to cross cell
membranes and binds chromatin) and propidium iodide (PI, which
only cross damaged membranes and binds chromatin) staining in live
cells. After treatment in coverslips, ECs were washed two times with
PBS at 37 °C, incubated with 15 μg/ml Hoechst 33342 and 3 μg/ml PI
in PBS for 5 min in the dark, washed again two times with PBS and
mountedwith PBS at 37 °C on amicroscope slide and observed in aﬂuo-
rescence microscope (Zeiss axioskop2, Zeiss, Jena, Germany) using a
40× objective. Viable cells display a normal nuclear size without PI
staining. The cells with normal nuclear sizewith PI stainingwere scored
as necrotic cells. Scored apoptotic ECs include cells that display pyknotic
nuclei with condensed or fragmented chromatin with or without PI
staining (primary and secondary apoptotic cells). All experiments
were performed three times in duplicate, and a minimum of 150 cells
were scored for each coverslip. The number of apoptotic and necrotic
cells were expressed as the percentage (%) of the total number of cells
in all microscope ﬁelds for each coverslip.
2.7. Western blot analysis of ER stress and apoptotic markers
Protein levels of ER stress markers were evaluated by immunoblot-
ting using cellular extracts obtained from treated or untreated ECs.
First, cells were washed 2 times with PBS (pH 7.4) and scraped in ice
cold lysis buffer (in mM): 25 HEPES-Na, 2 MgCl2, 1 EDTA, 1 EGTA,
supplemented with 0.1 mMPMSF, 2 mMDTT, and 1:1000 of a protease
inhibitor cocktail (1 μg/ml leupeptin, pepstatin A, chymostatin, and
antipain). The cellular extracts were then rapidly frozen in liquid N2
and thawed, centrifuged for 1 min at 106 g at 4 °C and the supernatant
was collected. Apoptotic marker protein levels were also evaluated by
immunoblotting using cytosolic, nuclear or mitochondrial fractions
from treated or untreated ECs obtained with the ProteoExtract®
Subcellular Proteome Extraction Kit according to the manufacturer's in-
struction. The protein content was measured using the Bio-Rad protein
dye assay reagent.
Total cellular extracts containing 15 μg protein, or cytosolic, nuclear
and mitochondrial fractions containing 30 μg protein, were separated
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after denaturation at 95 °C for 5 min in sample buffer (in mM): 100
Tris, 100 DTT, 4% (v/v) SDS, 0.2% (w/v) bromophenol blue and 20%
(v/v) glycerol. To facilitate the identiﬁcation of proteins of interest, the
prestained Precision Plus Protein All Blue Standards was used. Proteins
were then transferred to PVDFmembranes, whichwere further blocked
for 1 h at RT with 5% (w/v) BSA in Tris-buffered saline (150 mM NaCl,
50 mM Tris, pH 7.6) with 0.1% (w/v) Tween 20 (TBS-T). The mem-
branes were next incubated overnight at 4 °C with a primary mouse
monoclonal antibody against GRP78 (1:1000 dilution in TBS-T), CHOP/
GADD153 (1:500 dilution in TBS-T), ATF4 (1:250 dilution in TBS-T), cy-
tochrome c (1:500 dilution in TBS-T) or AIF (1:1000 dilution in TBS-T)
or with a primary rabbit antibody against pro-caspase-12 (1:1000 dilu-
tion in TBS-T), ATF6α (1:1000 dilution in TBS-T), XBP1 (1:1000 dilution
in TBS-T), Bcl-2 (1:1000 dilution in TBS-T) or Bax (1:1000 dilution in
TBS-T). Control of protein loading was performed using a primary
mouse against GAPDH antibody (1:1000 dilution in TBS-T) or a primary
mouse anti-α-tubulin antibody (1:20,000 dilution in TBS-T) for total
cellular or cytosolic extracts, a primary rabbit anti-Tom20 antibody
(1:500 dilution in TBS-T) for mitochondrial extracts, and a primary
mouse against TBP antibody (1:2000 dilution in TBS-T) for nuclear
extracts. After washing, membranes were incubated for 1 h at RT with
an alkaline phosphatase conjugated secondary anti-mouse or anti-
rabbit antibody (1:20,000 dilution in TBS-T). Bands of immunoreactive
proteins were visualized after membrane incubation with ECF reagent
during approximately 5 min, on a Versa Doc 3000 Imaging System
(Bio-Rad, Hercules, CA, USA) and densities of protein bands were calcu-
lated using the WCIF ImageJ program (Wayne Rasband, Research Ser-
vices Branch, National Institute of Mental Health, Bethesda, Maryland,
USA). The ratios between pro-caspase-12, caspase-12, or AIF and
GAPDH, the ratios between GRP78, ATF6α, GADD153, XBP1, or ATF4
and α-tubulin, the ratios cytochrome c in mitochondria/total (cyto-
chrome c in mitochondria plus cytochrome c in the cytosol), or cyto-
chrome c in the cytosol/total and the ratios Bax/Bcl-2 in mitochondria
or Bax/Bcl-2 in the cytosol were calculated and results were normalized
to control values.2.8. Evaluation of ATF6 activation or PARP1 cleavage
by immunocytochemistry
In order to analyze the translocation of ATF6 to the nucleus or the
cleavage of PARP1 by caspases, treated or untreated ECs grown in
glass coverslips were rinsed two times with PBS (pH 7.4) and then
ﬁxed with 4% (w/v) paraformaldehyde at RT for 30 min. Cells were
then washed two times with PBS. Coverslip-plated ECs were perme-
abilizedwith0.2% (v/v) TritonX-100 for 2 min andwere then incubated
for 30 min at RT in blocking solution containing 3% (w/v) BSA in PBS to
prevent non-speciﬁc binding. Subsequently, cells were incubated dur-
ing 1 h at 4 °C with a primary rabbit anti-ATF6α antibody or against
the large fragment resulting from caspase cleavage of rat PARP1
(1:200 dilution in blocking solution). Thereafter, coverslips were rinsed
in PBS and incubated for 1 h at RT with the secondary antibody anti-
rabbit IgG labeled with Alexa Fluor 488 (1:200 dilution) diluted in PBS
with 1% (w/v) BSA. Following additional rinses in PBS, cellswere stained
in the dark for 5 min, at RT, with 15 μg/ml Hoechst 33342 prepared in
PBS. Finally, the preparations were mounted using Glycergel Mounting
Medium. Images were collected using a Zeiss LSM 510 Meta confocal
microscope (Carl Zeiss, New York, USA) with a 63× objective or in a
ﬂuorescence microscope (Zeiss axioskop2, Zeiss, Jena, Germany) with
a 40× objective. All experiments were performed three times in dupli-
cate, and a minimum of 100 cells were scored for each coverslip. For
ATF6α nuclear translocation analysis, the ﬂuorescence and the area of
cell nucleus were quantiﬁed using the WCIF ImageJ program (Wayne
Rasband, Research Services Branch, National Institute of Mental Health,
Bethesda, Maryland, USA) and the ratio ﬂuorescence/area calculated.2.9. Analysis of ER calcium content by single cell imaging with Fura-2/AM
The content of Ca2+ in the ER was measured by single cell Ca2+ im-
aging using the ﬂuorescent probe Fura-2/AM, according to the method
described by Ferreiro et al. [28]. Treated and untreated cells, plated in
glass coverslips, were washed 2 times in sodium medium without
Na2HPO4 (in mM: 132 NaCl, 4 KCl, 1 CaCl2, 1.4 MgCl2, 6 glucose, 10
HEPES-Na, pH 7.4) and supplemented with 10 mM NaHCO3, 0.05 mM
EGTA, and 0.1% (w/v) fatty acid-free BSA, pH 7.4. Then, cells were
loaded with 5 μM Fura-2/AM in the same medium supplemented with
0.2% (w/v) pluronic acid for 40 min, at 37 °C in the dark. Afterwards,
cells were washed 3 times in Ca2+-free Krebs medium and the cover-
slips were assembled to perfusion chamber, in the same Ca2+-free me-
dium, in an inverted ﬂuorescencemicroscope (Axiovert 200, Zeiss, Jena,
Germany). Cells were alternatively excited at 340 and 380 nm using a
Lambda DG4 apparatus (Sutter Instruments Company, Novaco, CA,
USA), and emitted ﬂuorescence at 510 nm was collected with a 40×
objective andwas driven to a coll SNAP digital camera (Roper Scientiﬁc,
Trenton, NJ, USA). After a baseline was established, cells were stimu-
lated with thapsigargin (2.5 μM), to empty ER Ca2+ stores. Acquired
valueswere processedusing theMetaFluor software (Universal Imaging
Corporation, Buckinghamshire, UK). The increase in 340/380 nmratio is
proportional to ER Ca2+ content and the absence of external Ca2+ guar-
antees that the increase in the Fura-2 ﬂuorescence ratio is due solely to
the release of Ca2+ from the ER. The peak amplitude of Fura-2 ﬂuores-
cence (ratio at 340/380 nm) was used to evaluate ER Ca2+ content
that was normalized to control values.
2.10. Measurement of cytosolic calcium concentration with Indo-1/AM
The cytosolic Ca2+ concentration was measured in RBE4 cells cul-
tured on 24-well plates. Cells were incubated in the dark with 3 μM
Indo-1/AM in sodium medium without Na2HPO4 for 45 min at 37 °C,
and were further incubated for 15 min in the absence of Indo-1/AM to
ensure a complete hydrolysis of the acetoxymethyl ester. Subsequently,
Indo-1 ﬂuorescence was measured in a microplate reader (SpectraMax
Gemini EM ﬂuorocytometer, Molecular Devices, California, USA) with
excitation at 350 nm and emission at 410 nm. The free cytosolic Ca2+
concentration was calculated using the Fmax and AF (Autoﬂuorescence)
values determined after the addition of ionomycin (3 μM) and MnCl2
(3 mM), respectively [43] and the results were expressed relatively to
the control.
2.11. Mitochondrial membrane potential measurements
TheΔψmit wasmeasured using the ﬂuorescent dye TMRM. This cat-
ionic indicator is accumulated preferentially into energized mitochon-
dria driven by the membrane potential. In the ﬁnal of the treatments,
RBE4 cells were washed with PBS and incubated with 300 nM TMRM
in sodium medium for 1 h at 37 °C in the dark. Then, the medium was
replaced by sodium medium at 37 °C and the ﬂuorescence was mea-
sured in a microplate reader (SpectraMax Gemini EM ﬂuorocytometer,
MolecularDevices, California, USA)with excitation at 540 nmand emis-
sion at 590 nm (F). 1 μM FCCP and 2 μg/ml oligomycin were added and
theﬂuorescencemeasured again (F0). The differences between F and F0
were calculated and the results were expressed relatively to untreated
cells.
2.12. Analysis of caspase-3,- 9-, and -12-like activity
The activation of caspases-3, -9, and -12was investigated in extracts
from control and treated RBE4 cells. After treatments, ECs were washed
two times with PBS at 4 °C and scraped in reaction buffer: 25 mM
HEPES-Na, 10% (w/v) sucrose, 10 mM DTT, and 0.1% (w/v) CHAPS
(pH 7.4). The cellular extract was rapidly frozen and thawed three
times in liquid N2, and then centrifuged for 10 min at 20,800 g at 4 °C.
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Bio-Rad protein dye assay reagent. Aliquots of cellular extracts contain-
ing 30 μg of proteinwere reactedwith 0.1 mMAc-DEVD-pNA (chromo-
genic substrate for caspase-3), Ac-LEHD-pNA (chromogenic substrate
for caspase-9) or Ac-LEVD-pNA (chromogenic substrate for caspase-
12), in reaction buffer for 2 h at 37 °C. Caspase-3, -9, and -12-like activ-
ity was determined by measuring substrate cleavage at 405 nm in a
microplate reader (SpectraMax Plus 384) and results were expressed
relatively to the control.
2.13. Data analysis
Data were expressed as means ± SEM of measurements performed
in duplicate, from at least three independent experiments. Statistical
signiﬁcance analysis was determined using one-way ANOVA followed
by Dunnett's post hoc tests or using Student's t-test in the GraphPad
Prism Software (San Diego, CA, USA). The differences were considered
signiﬁcant for P values b 0.05.
3. Results
3.1. Aβ1–40 peptide decreases brain endothelial cell survival and activates
apoptotic cell death
Previously, we have shown that the addition of Aβ40–1 to cell culture
medium does not signiﬁcantly affect cell's morphology and survival
[37,44], demonstrating the speciﬁcity of the amino acid sequence of
Aβ1–40. Here, incubation of RBE4 cells for 3–24 h with 0.1 or 2.5 μM
Aβ1–40, which forms small aggregates in culture (Fig. 1A), decreased
cell survival, as evaluated by the MTT assay, in a dose- and time-
dependent manner (Fig. 1B). A statistical signiﬁcant decrease in theFig. 1.Aβ1–40 decreases brain endothelial cell survival activating apoptotic cell death. (A) RBE4 c
and observed with 400× ampliﬁcation in a confocal microscope. (B) Additionally, cells were tr
MTT assay. Data correspond to the percentage of the absorbance determined under control cond
Aβ1–40 and the release of LDHwasmeasured to monitor necrosis-associated loss of plasmamem
lular medium and are presented relative to control. (D–G) Furthermore, cells were incubated w
with Hoechst 33342/PI staining (D and E) or by the TUNEL assay (F and G). In (D) are represente
theﬂuorescence (green) and themerged images of TUNEL-stained cells visualizedwith 400× am
cells, presented as the percentage of total number of cells (E and G), was quantiﬁed. Data repre
***p b 0.001 signiﬁcantly different from control.ability to reduce MTT, and thus in cell viability, was observed when
RBE4 cells were exposed to 0.1 μM Aβ1–40 for 12 or 24 h or to 2.5 μM
Aβ1–40 for 3 or more hours. Accordingly with these results, the Aβ1–40
concentration of 2.5 μM was used in subsequent studies. Aβ1–40 was
shown to preserve the integrity of the plasma membrane since no sig-
niﬁcant release of LDH occurred after 6 or 24 h (Fig. 1C), suggesting
that necrosis doesn't contribute to Aβ-induced cell death in brain ECs.
These results were corroborated with Hoechst 33342/PI showing that
the number of necrotic cells was not affected by Aβ1–40 treatment
(Fig. 1D and E).Moreover, in RBE4 cells treatedwith 2.5 μMAβ1–40 dur-
ing 24 h, there is a signiﬁcant increase in the number of apoptotic cells,
as determined using Hoechst 33342/PI staining (Fig. 1D and E) and the
TUNEL assay (Fig. 1F and G). Taken together, these results show that
Aβ1–40 is toxic to brain ECs compromising cell survival and leading to
the activation of an apoptotic cell death pathway.
3.2. Aβ1–40 induces ER stress in brain endothelial cells
The levels of several ER stress markers were determined in Aβ1–40-
treated brain ECs by Western Blot (WB). Signiﬁcant increases in pro-
teins levels of ATF4 (Fig. 2A and B) (activated downstream of the
PERK ER stress sensor), unspliced XBP1 (Fig. 2A and C) (the transcrip-
tion of XBP-1 gene increases upon UPR activation), spliced XBP1
(Fig. 2A and D) (downstream of the IRE1α ER stress sensor), active
ATF6α (Fig. 2A and E) (the 55 kDa fragment that results from ATF6α
cleavage within the Golgi apparatus), and the ER chaperone GRP78/
BiP (Fig. 2A and F) were observed in RBE4 cells treated with Aβ1–40 for
3, 6, or 12 h, but not 24 h. The subcellular localization of ATF6α was
also followed by immunocytochemistry and a signiﬁcant increase in
ATF6α staining was observed in cells treated with Aβ1–40 for 6 h, espe-
cially in the nucleus, comparatively to that detected in control cells inells treatedwith 2.5 μMAβ1–40 for 3 h were stainedwith ThS to detect β-sheet Aβ species
eated with 0.1 or 2.5 μM Aβ1–40 for 3, 6, 12, or 24 h and cell viability was evaluated by the
itions (untreated cells). (C)Moreover, RBE4 cellswere incubated for 6 or 24 hwith 2.5 μM
brane integrity. The results correspond to the percentage of LDH released to the extracel-
ith 2.5 μM Aβ1–40 for 24 h and the number of apoptotic and necrotic cells was measured
d the Hoechst 33342, PI andmerged images and in (F) are represented the phase contrast,
pliﬁcation. Aminimumof 150 cellswere scored for each coverslip and the number of dead
sent the means ± SEM of at least three independent experiments performed in duplicate.
Fig. 2.Aβ1–40 induces ER stress in brain endothelial cells. RBE4 cellswere treatedwith 2.5 μMAβ1–40 peptide for 3, 6, 12, or 24 h and thenATF4 (A andB), unsplicedXBP-1 (A andC), spliced
XBP1 (A and D), cleaved ATF6α (A and E), and GRP78 (A and F) protein levels were quantiﬁed byWB. Proteins (15 μg) from cell lysates were separated by SDS-PAGE and immunoblotted
with speciﬁc antibodies. An anti-α-tubulin antibodywas applied as a protein loading control and used to normalize ER stress protein levels. The resultswere calculated relatively to control
values and represent themeans ± SEM of at least eight independent experiments. (G andH) Additionally, cells cultured in glass coverslipswere incubatedwith 2.5 μMAβ1–40 for 6 h and
thenuclear localization of ATF6αwas analyzed by immunocytochemistry using an antibody against ATF6α andHoechst 33342 to label nuclei. (G) Fluorescence images of control and treat-
ed cells were visualized with 630× ampliﬁcation in a confocal microscope. (H) The ATF6α staining in the nucleus of a minimum of 100 cells for each coverslip was measured using the
WCIF ImageJ program. Results were calculated as the means ± SEM of at least three independent experiments performed in duplicate and were normalized to control values.
*p b 0.05, **p b 0.01, and ***p b 0.001 signiﬁcantly different from control.
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translocation of cleaved ATF6α under these conditions. These results
demonstrate that ER stress is activated in ECs exposed to toxic Aβ1–40
concentrations.3.3. ER and cytosolic calcium homeostasis is impaired by Aβ1–40 in brain
endothelial cells
The levels of Ca2+ in the ER and in the cytosol were analyzed in ECs
treatedwith 2.5 μMAβ1–40 for 3 or 24 h and for 3, 6, 12, or 24 h, respec-
tively. Under these conditions, the ER Ca2+ content was shown to be
signiﬁcantly depleted in RBE4 cells after Aβ1–40 treatment, as analyzed
by single cell Ca2+ imaging with Fura-2/AM (Fig. 3A and B). Moreover,a signiﬁcant rise in cytosolic Ca2+ levels measured with Indo-1/AMwas
observed in Aβ1–40-treated cells (Fig. 3C). These results suggest that
Aβ1–40 impairs ER Ca2+ homeostasis leading to the early release of
Ca2+ from ER subsequently increasing cytosolic Ca2+ levels. Changes
in ER Ca2+ content are correlated with activation of ER stress sensors
(Fig. 2). In addition, impairment of Ca2+ homeostasis precedes activa-
tion of apoptotic cell death (Fig. 1D–G).3.4. Activation of the ER stress–mediated apoptotic pathway in
Aβ1–40-treated brain endothelial cells
The levels of CHOP/GADD153, a pro-apoptotic transcription factor
that is activated under ER stress conditions, were shown to be affected
Fig. 3. ER and cytosolic Ca2+ content is affected in Aβ1–40-treated brain endothelial cells.
(A) The ﬂuorescence ratio at 340/380 nm of the Ca2+-sensitive probe Fura-2/AM was
monitored in the absence of external Ca2+ in controls and in cells treated with Aβ1–40
for 3 or 24 h. After establishment of a basal ﬂuorescence signal, 2.5 μM thapsigargin was
added to deplete ER Ca2+ content. A representative experiment is presented in. (B) The
peak amplitude of Fura-2 ﬂuorescence was used to evaluate ER Ca2+ content. (C) Addi-
tionally, cytosolic Ca2+ levels were analyzed using the Ca2+ dye Indo-1/AM after treat-
ment of RBE4 cells with 2.5 μM Aβ1–40 for 3, 6, 12, or 24 h. Data were normalized to
control and represent the means ± SEM of at least three independent experiments
performed in duplicate. **p b 0.01 and ***p b 0.001 signiﬁcantly different from untreated
cells.
Fig. 4. CHOP protein levels are increased by Aβ1–40 treatment in brain endothelial cells.
RBE4 cells were treated with 2.5 μM Aβ1–40 for 3, 6, 12, or 24 h and then CHOP protein
levels were quantiﬁed by WB. Protein (15 μg) obtained from cell lysates was separated
by SDS-PAGE and immunoblotted with the respective antibody. An anti-α-tubulin anti-
body was used as a protein loading control and used to normalize CHOP protein levels
(A and B). The results were normalized to control and represent the means ± SEM of at
least eight independent experiments. **p b 0.01 signiﬁcantly different from control.
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increase observed at 3 and 6 h of treatment (Fig. 4). Cytochrome c,
Bax and Bcl-2 protein levels were also analyzed in cytosolic and mito-
chondrial sub-cellular fractions by WB and Δψmit after 3, 6, 12, or
24 h of incubation with Aβ1–40 (Fig. 5). The ratio between Bax and
Bcl-2 protein levels in mitochondria was signiﬁcantly augmented with
a maximal increase at 12 h of treatment with Aβ1–40 (Fig. 5B). Concom-
itantly, this ratio decreased in the cytosol but statistical signiﬁcance was
only observed at 3 h (Fig. 5C). Cytochrome c levels were signiﬁcantly
decreased in mitochondria (Fig. 5D) and increased in cytosol (Fig. 5E)
with a maximum release from mitochondria determined after 12 h of
treatmentwith Aβ1–40. In addition,Δψmit decreased upon Aβ1–40 treat-
ment with a minimum at 12 h (Fig.5F) that was reverted by dantrolene
(Fig. 5G). These results suggest that activation of CHOP/GADD153 under
Aβ1–40-induced ER stress conditions promotes the translocation of Bax
from the cytosol to the mitochondria, decreasing Δψmit and leading to
cytochrome c release.
The activation of the ER resident caspase-12 was byWB. After expo-
sure of RBE4 cells to Aβ1–40 during 3, 6, 12 or 24 h, the levels of pro-
caspase-12 were not signiﬁcantly altered (Fig. 6A and B) but the levels
of the active form caspase-12 increased until 12 h of Aβ1–40 treatment
returning to control values at 24 h (Fig.6A and C). Furthermore,
caspase-12-like activity was shown to be increased in Aβ1–40-treated
cells after 6 and 12 h incubation, but not at 24 h (Fig. 6D). Similarly, a
signiﬁcant increase in caspase-like activities of caspase-9 (Fig. 6E) and
caspase-3 (Fig. 6F) was determined 6 and 12 h after Aβ1–40 exposure,but not at 24 h. The cleavage of PARP1 by caspases, namely caspase-3,
after incubation of RBE4 cells with 2.5 μM Aβ1–40 during 12 or 24 h
was evaluated by immunocytochemistry using a speciﬁc antibody,
which recognizes the large fragment with 89 kDa of PARP1 resulting
from caspase cleavage at Asp214, and Hoechst 33342 to label nuclei.
An increase in cleaved PARP1 was observed in Aβ1–40-treated cells
both after 12 and 24 h incubation (Fig. 6G). Together, these results dem-
onstrate that Aβ-induced ER stress leads to apoptotic cell death in ECs
through mitochondria-independent pathways, mediated by caspase-
12 activation, but also through mitochondria-dependent pathways
that rely on the release of mitochondrial cytochrome c upon Bax trans-
location to mitochondria and subsequent activation of caspases-9 and
-3 ﬁnally leading to cleavage of apoptosis substrates and cell death.
3.5. Aβ1–40-treatment induces the translocation of AIF to the nucleus
The release of AIF from mitochondria and subsequent translocation
to the nucleus were evaluated by WB in mitochondrial and nuclear ex-
tracts obtained from control and Aβ1–40-treated RBE4 cells for 3 to 24 h.
The content of AIF in the cytosol was very low (Fig. 7A) suggesting that
AIF released frommitochondriawas rapidly degraded or translocated to
the nucleus. After 24 h of Aβ1–40 treatment, a slight decrease in mito-
chondrial AIF content (Fig. 7A and B) and a signiﬁcant increase in AIF
levels in the nucleus (Fig. 7A and C) were observed. These ﬁndings sup-
port that Aβ1–40-induced Bax translocation to themitochondria also ac-
tivates AIF-mediated caspase-independent cell death pathways.
4. Discussion
The results here presented using brain ECs treated with Aβ1–40 high-
light the role of the ER stress-mediated apoptotic cell death pathway in
vascular alterations that occur in AD brain. This hypothesis is supported
by our ﬁndings demonstrating that Aβ1–40: i) compromises EC survival;
ii) induces ER stress, increasing the levels of severalmediators of UPR sig-
naling pathways; iii) induces loss of ER Ca2+ homeostasis concomitantly
increasing cytosolic Ca2+ levels; iv) upregulates the ER stress-associated
pro-apoptotic transcription factor CHOP/GADD153; v) activates a
Fig. 5. The mitochondria-mediated apoptotic cell death pathway is activated by Aβ1–40 in
brain endothelial cells. After treatment of RBE4 cells with 2.5 μM Aβ1–40 for 3, 6, 12, or 24 h,
mitochondrial and cytosolic extracts were prepared and proteins (30 μg) were separated by
SDS-PAGE and immunoblotted with anti-Bcl-2, anti-Bax (A, B and C), and anti-cytochrome
c (A, D and E) antibodies. Anti-Tom20 and anti-GAPDH antibodies were applied as protein
loading control for mitochondrial and cytosolic fractions respectively. Bax/Bcl-2 ratio in the
mitochondria (B) and in the cytosol (C) was calculated. The ratio between mitochondrial
and total (cytosolic plus mitochondrial) cytochrome c levels (D) and the ratio between cyto-
solic and total cytochrome c levels (E)were also calculated. Additionally, theΔψmitwasmea-
sured upon Aβ1–40 (F) and dantolene (G) treatment of RBE4 cells using the ﬂuorescent probe
TMRM. The results were normalized to control and represent the means ± SEM of at least
ﬁve independent experiments. *p b 0.05, **p b 0.01, and ***p b 0.001 signiﬁcantly different
from control and ###p b 0.001 signiﬁcantly different from Aβ1–40 treated ECs.
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tion of the ER resident caspase-12; vi) triggers the early translocation
of Bax to mitochondria leading to cytochrome c release and subsequentcaspase-9 and caspase-3 activation (caspase-dependent pathway) and
also to the release of AIF frommitochondria and translocation to the nu-
cleus (caspase-independent pathway).
AD patients frequently have deposits of Aβ in cerebral arteries,
veins and capillaries possibly due to reduced trans-endothelial
clearance of Aβ [7]. Previous studies demonstrate that Aβ could
deregulate ECs causing morphological and functional alterations
and inducing apoptosis [9,13,14]. However, the mechanisms re-
sponsible for Aβ-induced apoptotic cell death in these cells have
not been fully elucidated. In this study, we demonstrated that
Aβ1–40 affects the survival of brain ECs in a dose- and time-
dependent manner using the RBE4 cell line. Furthermore, we
were able to show that toxic concentrations of Aβ1–40 increase the
percentage of apoptotic cells, in the absence of signiﬁcant alter-
ations in the number of necrotic cells.
We previously demonstrated that Aβ induces neuronal apoptosis
through ER stress activation [37,38]. In ECs, ER stress and consequent
activation of UPR have been reported to be triggered by several stimuli
[45–47]. Some metabolic diseases associated with vascular abnormali-
ties, such as obesity and type 2 diabetes, are risk factors for AD [48]
and are known to affect Aβ production [49]. Moreover, several studies
indicate that ER stress contributes to the pathogenesis of obesity and di-
abetes [50]. Aβ1–40 inhibits human brain vascular EC proliferation [14]
and induces apoptosis [51]. However, the role of Aβ in the ER stress re-
sponse in brain ECs is unknown. To demonstrate the effect of Aβ in the
ER stress response in these cells, the levels of ATF4, spliced XBP-1, and
cleaved ATF6α, which occur downstream of the activation of the ER
stress sensors PERK, IRE1, and ATF6, respectively, and also of GRP78, a
molecular chaperone, and unspliced XBP-1 that are ER stress target
genes [17], were analyzed after Aβ1–40 treatment. A signiﬁcant increase
in the levels of these ER stress markers was detected in Aβ1–40-treated
RBE4 cells clearly indicating that Aβ1–40 activates the ER stress-
associated UPR signaling pathways in brain ECs.
One of the functions of vascular ECs from the BBB is to remove Aβ
from the brain. The accumulation of proteins inside the ER, which acti-
vates the UPR and consequently inhibits protein translation, decreases
the trafﬁc of proteins in the secretory pathway. Consequently, the levels
of Aβ transporters at the plasmamembrane can decrease leading to Aβ
accumulation in brain. Accordingly, the ratio between Aβ efﬂux and in-
ﬂux in AD patients' brain is decreased compared to healthy subjects
showing that Aβ clearance from the brain is compromised in the disease
[52]. Moreover, ER stress was demonstrated to increase Aβ production
and subsequent accumulation [53]. The accumulation of misfolded/
unfolded proteins in the ER is accompanied by alterations in ER Ca2+
homeostasis. Furthermore, familial AD mutations in PSs, components
of the γ-secretase complex involved in Aβ production [54], have been
linked to the perturbation of Ca2+ homeostasis [55–57]. For instance,
PS1 holoprotein seems to form a complex with the SERCA channel and
contribute to the regulation of ER Ca2+ levels [58]. Consequently, alter-
ations in PSs that impair the formation of ER Ca2+ leak channels cause
neurodegeneration independent of γ-secretase activity [56]. It was
also found that some sporadic AD brains preferentially express an alter-
native splicing form of PS2 (lacking exon 5) compared with those
of age-matched controls [59]. When ER Ca2+ levels decrease, the
Ca2+-dependent chaperones cannot function properly and misfolded/
unfolded proteins accumulate within the ER activating the UPR [60].
Alteration of intracellular Ca2+ concentration, reactive oxygen species,
blocked ER-to-Golgi transport, inhibition of protein degradation, de-
crease in ATP levels and other insults may also cause ER stress and re-
lease of Ca2+ from the ER lumen into the cytoplasm [61]. Previously,
we demonstrated in primary cultured neurons that Aβ induces the re-
lease of Ca2+ from the ER leading to cytosolic Ca2+ rise and activation
of apoptotic cell death [38]. Here, ER Ca2+ content was shown to be
decreased in brain ECs, and to be followed by a signiﬁcant increase in
cytosolic Ca2+ levels upon Aβ1–40 exposure. These ﬁndings are in accor-
dance with the results obtained by Kito and co-workers who
Fig. 6. Aβ1–40 treatment activates caspases-3, -9, and -12 in brain endothelial cells and induces PARP1 cleavage. (A–C) RBE4 cells were treated with 2.5 μMAβ1–40 for 3, 6, 12, or 24 h and
then pro-caspase-12 and caspase-12 protein levels were quantiﬁed by WB. Proteins (15 μg) obtained from cell lysates were separated by SDS-PAGE and immunoblotted with a speciﬁc
antibody and an anti-GAPDH antibody applied as a protein loading control. The ratio between pro-caspase-12 (B) or caspase-12 (C) and GADPH was calculated. The presented results
were normalized to control values and represent the means ± SEM of at least ﬁve independent experiments performed in duplicate. In addition, caspase-12 (D), caspase-9 (E), and
caspase-3 (F)-like activities were determined in cell lysates using the colorimetric substrates Ac-LEVD-pNA, Ac-LEHD-pNA, and Ac-DEVD-pNA, respectively. The presented results were
normalized to control and represent the means ± SEM of at least three independent experiments performed in duplicate. (G) Moreover, RBE4 cells cultured in glass coverslips were in-
cubatedwith 2.5 μMAβ1–40 for 12 or 24 h and the cleavage of PARP1was analyzed by immunocytochemistry using an antibody against the large fragment of PARP1 resulting from caspase
cleavage at Asp214 and Hoechst 33342 to label nuclei. Fluorescence images of control and treated cells were visualized with 400× ampliﬁcation. *p b 0.05 and ***p b 0.001 signiﬁcantly
different from untreated cells.
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Fig. 7. Aβ1–40 induces the translocation of AIF to the nucleus in brain endothelial cells.
After treatment of RBE4 cells with 2.5 μM Aβ1–40 for 3, 6, 12, or 24 h, cytosolic (A), mito-
chondrial (A and B) and nuclear (A and C) extracts were prepared and proteins (30 μg)
were separated by SDS-PAGE and immunoblotted with an anti-AIF antibody. Anti-
GAPDH (for cytosolic fractions), anti-Tom20 (for mitochondrial fractions) and TBP
(for nuclear fractions) antibodieswere applied as protein loading control and used to nor-
malize AIF protein levels. The results were normalized to control and represent the
means ± SEMof at least six independent experiments. **p b 0.01 and ***p b 0.001 signif-
icantly different from control.
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lular Ca2+ levels [47].
The release of Ca2+ from ER and consequent increase in cytosolic
Ca2+ levels can activate pathways that culminate in apoptosis [62–64].
Deregulation of the BBB is a primary event in AD, which occurs before
neuronal loss that underlies the prominent brain atrophy found in the
brain of patients [5,65]. The activation of apoptosis in the brain of AD pa-
tients is a controversial issue, but several studies found activation of
caspase-3 in AD patients [66]. Additionally, recent studies also show ap-
optosis in vascular cells in AD patients [67]. Furthermore, several in vitro
studies found that Aβ induces apoptosis in neurons, ECs, pericytes, and
other brain cells [38,68,69]. Moreover, cerebrovascular accumulation
of Aβ in mice was shown to induce apoptotic cell death in ECs [8]. In
our previous studies, we demonstrated the involvement of ER Ca2+
release induced by different Aβ peptides in mitochondria-mediated ap-
optosis in cortical neurons and AD cybrids [28,38,70]. Thapsigargin-
mediated perturbation in Ca2+ homeostasis was shown to lead to apo-
ptosis in a cross-talk between the death receptor and mitochondrial
pathways [71]. Ca2+ channels associated with the ER ryanodine
receptor (RyR) are involved in Ca2+ homeostasis and control ER-to-
mitochondria Ca2+ transfer [72]. The prevention of Aβ1–40-induced de-
crease in Δψmit promoted by dantrolene, an RyR inhibitor, demon-
strates the involvement of Ca2+ released from the ER in mitochondrial
membrane depolarization and consequent induction of mitochondria-
dependent apoptosis in ECs. After prolonged or intense activation of
UPR and perturbation of ER Ca2+ homeostasis, the pro-apoptotic tran-
scription factor CHOP/GADD153 can be upregulated [24,73]. In turn,
CHOP/GADD153 upregulates the pro-apoptotic BH3-only protein Bim
[74], inhibits the transcription of the anti-apoptotic Bcl-2 protein and in-
duces the translocation of Bax tomitochondria and the subsequent cyto-
chrome c release and activation of caspase-9 and -3, ﬁnally leading to
apoptosis [26,75]. Therefore, the reduction in ER Ca2+ content, as well
as the activation of ER stress and the consequent augment of CHOP/
GADD153 protein levels can induce mitochondria-mediated apoptosisthus explaining the decrease in cell viability and the increase in the
number of apoptotic cells observed after Aβ1–40 treatment. To conﬁrm
this hypothesis, Bcl-2, Bax, and cytochrome c protein levels were
analyzed in mitochondrial and cytosolic fractions of RBE4 cells and
Δψmit was measured. The Bax/Bcl-2 ratio, which could be used to pre-
dict mitochondria-mediated apoptosis, increased in mitochondria, es-
pecially due to an increase of Bax levels, and decreased in cytosol in
Aβ1–40-treated cells, suggesting that Aβ1–40 induces the translocation
of Bax to mitochondria. Bax can form pores in the mitochondrial mem-
brane permitting the release of ions and consequently decrease in
Δψmit. Moreover, cytochrome c can be released from mitochondria
and induce apoptosis. Accordingly, cytochrome c levels were signiﬁ-
cantly decreased in mitochondria and increased in cytosol after incuba-
tion with Aβ1–40 and the downstream caspase-9 was shown to be
activated under these conditions. Furthermore, the activity of caspase-
3 increased upon Aβ1–40 treatment leading to the cleavage of PARP1, a
DNA repair enzyme [76]. These alterations in pro-apoptotic mediators
follow changes in ER and cytosolic Ca2+ homeostasis, ER stress markers
and precede the decrease in cell viability and the increase in the number
of apoptotic cells suggesting that Aβ1–40 activates a mitochondrial-
mediated apoptotic cell death pathway triggered by ER stress in
brain ECs. During prolonged ER stress, the ER membrane resident
caspase-12 can be activated subsequently initiating a mitochondria-
independent caspase cascade that ﬁnally leads to apoptosis [17].
Caspase-12 is activated under ER stress conditions, including disruption
of ER Ca2+ homeostasis and excessive accumulation of proteins in ER
lumen, but not by membrane- or mitochondrial-targeted apoptotic sig-
nals [77]. Additionally, the increase in cytosolic Ca2+ levels resulting
from ER stress activates calpains that in turn activate the murine
caspase-12 [78,79]. However, UPR induction in the absence of caspase-
12 activation has also been previously found in ECs [80]. In this work,
the protein levels of caspase-12 were signiﬁcantly increased in Aβ1–40-
treated ECs together with an increase in caspase-12-like activity, which
reached maximal activation at 12 h of incubation. Caspase-12 can acti-
vate caspase-9 (in an Apaf-1 and cytochrome c independent manner)
that in turn activates the apoptosis effector caspase-3 [78]. Aβ1–40 activat-
ed both caspase-3 and -9 after 6 and 12 h incubation. These results sup-
port that Aβ-induced ER stress triggers apoptotic cell death in brain ECs
also by mitochondria-independent cell death pathways.
In this study, caspase-12 activation and Bax translocation into mito-
chondria and subsequent cytochrome c release and caspases-9 and -3
activation have a maximum increase 12 h after Aβ1–40 treatment but de-
creased at 24 h. However, cell viability continues to decrease and the
number of apoptotic cells continues to increase at 24 h of incubation.
These ﬁndings suggest that alternative mechanisms must be implicated
in the compromise in cell survival and signiﬁcant apoptotic cell death at
later stages (24 h). It is known that Aβ in brain patients with AD exces-
sively increase PARP1 activity, also present in mitochondria, leading to
the accumulation of poly(ADP-ribose) that in turn induces the release
of AIF from mitochondria and consequent translocation to the nucleus
[81]. Furthermore, activation of calpains after increase in cytosolic Ca2+,
alterations in Δψmit and the formation of pores in mitochondrial mem-
brane by Bax or other pro-apoptotic Bcl-2 familymember could also pro-
mote AIF release frommitochondria and its nuclear translocation [82,83].
In the nucleus, AIF leads to chromatin condensation and DNA fragmenta-
tion and triggers caspase-independent apoptosis [84]. Accordingly, treat-
ment of RBE4 cells with Aβ1–40 for 24 h increased the levels of AIF in the
nucleus. The AIF-mediated apoptosis can partially explain the differences
in the percentage of cell death measured by the TUNEL assay versus
Hoechst 33342/PI since the morphology of the nucleus during apoptosis
induced by AIF is not easily discriminated from that of controls [84].
The ER is a key regulator of several cellular processes and therefore
its dysfunction might compromise seriously cell survival [85]. The acti-
vation of the UPR is a protective mechanism to counteract ER stress and
re-establish homeostasis. However, when ER stress is prolonged or too
severe, apoptotic cell death is induced, which can occur through
Fig. 8. Aβ triggers apoptosis in brain endothelial cells through activation of stress responses and deregulation of Ca2+ homeostasis in the ER. Aβ induces the release of Ca2+ and accumu-
lation of unfolded proteins in the endoplasmic reticulum(ER) leading to the activation of the ER stress-mediatedUPR (activation of ATF6, IRE1, and PERK signaling pathways). Consequent-
ly, the transcription factors cleaved ATF6, spliced XBP-1 (sXBP-1), and ATF4 are translocated to the nucleus and induce the transcription of several genes such as the pro-apoptotic CHOP
that increases the Bax/Bcl-2 ratio in mitochondria leading to the release of cytochrome c and AIF. Cytochrome c binds to Apaf-1 and activates caspase-9, which in turn activates the apo-
ptosis effector caspase-3. On the other hand, severe ER stress is associatedwithmassive release of Ca2+ from ER and activates caspase-12 that activates caspase-9 independently of Apaf-1.
After translocation to the nucleus, AIF promotes chromatin condensation and DNA fragmentation resulting in apoptosis. PARP1 can repair DNA damage; however it is cleaved by caspases
such as caspase-3 during apoptosis.Moreover, the Ca2+ released fromER is transferred tomitochondria, causing Ca2+overload anddecrease ofmitochondrialmembrane potential (Δψm),
leading to the release of apoptotic factors.
2201A.C.R.G. Fonseca et al. / Biochimica et Biophysica Acta 1832 (2013) 2191–2203different mechanisms (CHOP upregulation, caspase-12 activation, JNK
activation…) [86]. Since the ER sensors IRE1, ATF6 and PERK and down-
stream UPR signaling pathways are implicated in both cell survival and
death, ER stress inhibitors can prevent ER stress-induced cell death but
can also interfere with cell survival pathways and impair the numerous
ER-dependent cellular functions. For that reason, we do not expect that
strategies to prevent UPR activation can revert the toxic Aβ effects, since
loss of protective pathways will turn cells more sensitive to stress.
Accordingly, we tested several ER stress inhibitors such as TUDCA
(tauroursodeoxycholic acid), PBA (4-phenylbutyric acid), VPA (valproic
acid sodium), alone or in combination, in ECs treated with two well
known ER stress inducers, thapsigargin and brefeldin A, or with Aβ
and we were not successful in protecting cells from ER stress-induced
apoptosis (data not shown). In addition, we cannot exclude the activa-
tion of ER-independent cell death pathways by Aβ, which are not res-
cued by ER stress inhibitors. Finally, the increases in the levels of
CHOP and caspase-12, as well as in caspase-12 activity in Aβ-treated
ECs, support that this peptide induces an ER stress-mediated apoptotic
cell death pathway.5. Conclusion
In conclusion, our ﬁndings support that vascular alterations in AD
arise from the deleterious effects of Aβ1–40 on brain ECs that activate
cell death pathways through the perturbation of ER Ca2+ homeostasis
and induction of ER stress (Fig. 8). These evidences could contribute to
the development of novel therapeutic strategies targeting the ER to pre-
vent or delay the progression of AD.Disclosure statement
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